Key result
Patients with cardiorenal syndrome type 1 had higher levels of IL-6, IL-18, and myeloperoxidase compared to those with acute heart failure alone.
Why the study?
Do patients with acute heart failure and cardiorenal syndrome type 1 have higher levels of proinflammatory cytokines and oxidative stress markers compared to those without?
Observational (n=53)
Do patients with acute heart failure and cardiorenal syndrome type 1 have higher levels of proinflammatory cytokines and oxidative stress markers compared to those without?
Patients with cardiorenal syndrome type 1 exhibit significantly higher levels of proinflammatory cytokines, oxidative stress markers, and tissue damage markers compared to acute heart failure patients without this complication.
Answers are grounded in this paper and cite their sources.
Elevated markers in CRS type 1 should not yet change practice; hypothesis-generating for targeted anti-inflammatory trials.
BACKGROUND: Cardiorenal syndrome type 1 (CRS type 1) is characterized by a rapid worsening of cardiac function leading to acute kidney injury (AKI). Inflammation and oxidative stress seem to play a pivotal role in its pathophysiology. In this in vivo study, we examined the putative role of inflammation and humoral markers in the pathogenesis of the CRS type 1. METHODS: We enrolled 53 patients with acute heart failure (AHF); 17 of them developed AKI (CRS type 1). The cause of AKI was presumed to be related to cardiac dysfunction after having excluded other causes. We assessed the plasma levels of proinflammatory cytokines (TNF-α, IL-6, IL-18, sICAM, RANTES, GMCSF), oxidative stress marker (myeloperoxidase, MPO), brain natriuretic peptide (BNP), and neutrophil gelatinase-associated lipocalin (NGAL) in AHF and CRS type 1 patients. RESULTS: We observed a significant increase in IL-6, IL-18, and MPO levels in CRS type 1 group compared to AHF (p < 0.001). We found higher NGAL at admission in the CRS type 1 group compared to the AHF group (p = 0.008) and a positive correlation between NGAL and IL-6 (Spearman's rho = 0.45, p = 0.003) and between IL-6 and BNP (Spearman's rho = 0.43, p = 0.004). We observed lower hemoglobin levels in CRS type 1 patients compared to AHF patients (p < 0.05) and inverse correlation between hemoglobin and cytokines (IL-6: Spearman's rho = -0.38, p = 0.005; IL-18: Spearman's rho = -0.32, p = 0.02). CONCLUSION: Patients affected by CRS type 1 present increased levels of proinflammatory cytokines and oxidative stress markers, increased levels of tissue damage markers, and lower hemoglobin levels. All these factors may be implicated in the pathophysiology of CRS type 1 syndrome.
No takes yet. Share an insight, caveat, or question.
Virzì et al. (2018) conducted an observational in Acute heart failure and Cardiorenal syndrome type 1 (n=53). Cardiorenal syndrome type 1 vs. Acute heart failure without cardiorenal syndrome type 1 was evaluated on Plasma levels of IL-6, IL-18, and myeloperoxidase (MPO) (p=<0.001). Patients with cardiorenal syndrome type 1 had higher levels of IL-6, IL-18, and myeloperoxidase compared to those with acute heart failure alone.
Synapse has enriched 10 related papers. Consider them for comparative context: